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ISObjective: To determine whether earlier initiation of antiretroviral therapy (ART) is
associated with better economic outcomes.
Design: Prospective cohort study of HIV-positive patients on ART in rural Uganda.
Methods: Patients initiating ART at a regional referral clinic in Uganda were enrolled in
the Uganda AIDS Rural Treatment Outcomes study starting in 2005. Data on labor force
participation and asset ownership were collected on a yearly basis, and CD4þ cell
counts were collected at pre-ART baseline. We fitted multivariable regression models
to assess whether economic outcomes at baseline and in the 6 years following ART
initiation varied by baseline CD4þ cell count.
Results: Five hundred and five individuals, followed up to 6 years, formed the
estimation sample. Participants initiating ART at CD4þ at least 200 were 13 percentage
points more likely to be working at baseline (P<0.01, 95% confidence interval 0.06–
0.21) than those initiating below this threshold. Those in the latter group achieved
similar labor force participation rates within 1 year of initiating ART (P<0.01 on the
time indicators). Both groups had similar asset scores at baseline and demonstrated
similar increases in asset scores over the 6 years of follow-up.
Conclusion: ART helps participants initiating therapy at CD4þ below 200 rejoin the
labor force, though the findings for participants initiating with higher CD4þ cell counts
suggests that pretreatment declines in labor supply may be prevented altogether with
earlier therapy. Baseline similarities in asset scores for those with early and advanced
disease suggest that mechanisms other than morbidity may help drive the relationship
between HIV infection and economic outcomes.
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The WHO recently recommended earlier initiation of
antiretroviral therapy (ART), in particular at CD4þT-cell
lymphocyte cell (CD4þ) count above 500 cells/ml [1].
These guidelines are based on evidence that earlier
initiation reduces morbidity and mortality and lowers the
risk of HIV transmission [2–4]. Earlier initiation may
confer significant economic benefits as well. A growing
body of work has shown that ART helps individuals
resume employment after having been too sick to
work [5–14]: earlier ART may prevent the pretreat-
ment declines in socioeconomic status altogether [15].
Moreover, earlier therapy may also augment subsequent
economic recovery if those initiating ARTat lower CD4þ
cell counts have difficulty achieving their pretreatment
economic status, perhaps due to reduced productivity
from persistent morbidity or lower social mobility.
At present, the relationship between CD4þ cell count at
initiation and the trajectory of economic status is not well
understood. A recent study demonstrated that individuals
with CD4þ above 200 in a rural Ugandan parish had
similar labor force participation rates as HIV-negative
individuals [15]. However, this study did not explicitly
focus on individuals on ART, nor did it examine
differences in economic outcomes over time. To address
this gap, we used data from an HIV cohort in rural
Uganda to examine whether earlier initiation of ARTwas
associated with a higher labor force participation rates
and greater household asset ownership, both at ART
initiation and through 6 years of follow-up.Methods
Participants, setting, and data
We used data from the Uganda AIDS Rural Treatment
Outcomes (UARTO) Study, an ongoing cohort study of
HIV-infected individuals initiating ART in rural, south-
western Uganda, started in 2005. Previously, ART-naı¨ve
persons 18 years of age or older initiating ART at the
Immune Suppression Syndrome Clinic of the Mbarara
Regional Referral Hospital were eligible for enrollment.
Survey instruments were translated into the local Bantu
language Runyankole, with interviews conducted by
a native Runyankole speaker. Ethical approval for the
study was obtained from the Mbarara University
of Science and Technology Institutional Review
Committee, the Committee on Human Research at
the University of California at San Francisco, and the
Partners Healthcare Human Research Committee.
Consistent with national guidelines, clearance for thestudy was granted by the Uganda National Council for
Science and Technology and the Research Secretariat
in the Office of the President.
Participants provided information on socioeconomic status
and basic demographic characteristics at baseline and at
yearly intervals thereafter. Our primary outcomes of
interest were labor force participation and household asset
ownership. Participants who reported engagement in any
income-generating activity, whether in the informal (self-
employment in trades, agriculture, etc.) or formal sectors at
the time of survey were considered as participating in the
labor force. For asset ownership, we created an index
representing the number of reported assets owned by the
household out of 16 different durable goods (see Table 1
notes). Our primary explanatory variable of interest was
baseline CD4þ cell count, which was obtained via serum
samples for all participants prior to initiating ART.
We partitioned the sample into persons initiating
ART at CD4þ below 200 vs. those initiating ART at
CD4þ at least 200.
Statistical analysis
We first plotted unadjusted trends in labor force
participation by CD4þ cell count at initiation. Second,
we fit a probit regression model specifying labor force
participation as the outcome variable and the following
explanatory variables: the baseline CD4þ cell count (<200
vs. 200); a set of binary indicators for each year since
ART initiation; and interactions between the CD4þ and
year indicators, so as to test whether the labor supply
response to ART differed between the CD4þ groups. We
adjusted our models for age and age-squared interacted
with sex, educational attainment, marital status, and season
of interview (March–May and October–November rainy
seasons). We presented labor force participation estimates
as marginal effects (i.e. the percentage point increase in the
probability of observing the dependent variable corre-
sponding to a one-unit change in a continuous explanatory
variable or a change from 0 to 1 for a dichotomous
explanatory variable). For the household asset scores,
we fitted regression models using ordinary least squares.
For both labor force participation and asset scores,
we examined trends through 6 years after ART initiation.
All analyses were conducted using Stata/SE 13.0 (Stata
Corp, College Station, Texas, USA).Results
Our sample consisted of 505 participants: 325 initiated
ART at CD4þ below 200 and 180 initiated ART at
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median CD4þ at initiation was 284 [interquartile
range (IQR) 233–360], with 47 (26%) initiating ART
at CD4þ at least 350. Women comprised 70% of
the sample and participants were, on average, surveyed
at five annual time points. At baseline, participants
initiating ART at CD4þ at least 200 were more likely
to be working compared to those initiating ART at
CD4þ below 200 (70 vs. 56%; x2¼ 9.15, P< 0.01),
but had similar asset index scores. Apart from marriage,
there were no statistically significant differences in base-
line characteristics (Table S1, http://links.lww.com/
QAD/A465).Figure 1 represents unadjusted trends in labor force
participation and asset ownership. Although participants
initiating ART at CD4þ below 200 were less likely to be
working at baseline, within 1 year of treatment initiation,
their average labor force participation rate converged to
that of the participants initiating ART at CD4þ at least
200. There were moderate increases for both groups
thereafter, with participation rates around 80% at 6-year
follow-up (Fig. 1a). For asset scores, both groups started
at similar levels and experienced gradual increases after
initiating ART (Fig. 1b).The multivariable regression results, shown in Table 1,
were consistent with the patterns in Fig. 1. As indicated
by the regression coefficients on the CD4þ cell count
variable, participants initiating ART at CD4þ at least
200 were 13 percentage points more likely to be
working at baseline [column 1; b¼ 0.13, 95% confidence
interval (CI) 0.06–0.21]. This group experienced
little change in labor force participation rates over
baseline in the ensuing years: the sum of the interacted
and noninteracted yearly indicator variables (which
recovers the total change in participation rates relative
to baseline for participants initiating ARTat CD4þ at least
200) was effectively zero for most of the 6 follow-up
years. Those initiating at CD4þ below 200, however,
did experience increased labor force participation: the
coefficients on the uninteracted yearly indicator variables
indicate a 12–20 percentage point increase in the
probability of working over baseline for each follow-up
year (F¼ 61.24, P< 0.01).For asset scores (column 2), participants in the high
CD4þ cell count group owned a similar number of
assets at baseline, and experienced gradual similar
increases after starting ART, as participants in the
low CD4þ cell count group: the time dummies
were collectively statistically significant (F¼ 6.25,
P< 0.01), but the coefficients on the interactions
with the CD4þ cell count dummy were not. For
both models, the associations between the outcomes and
schooling, sex, and age were in the expected directions
(Table S2, http://links.lww.com/QAD/A465).We additionally estimated models including individual
fixed effects, to control for time-invariant individual level
confounders; the results were unchanged. In addition, we
also excluded from the analysis all women who reported
being pregnant at baseline (since they may have been less
likely to work and more likely to access ART at higher
CD4þ cell counts). The substantive results again were
unchanged. We also considered sample attrition and
missing interview data, and ruled this out as a major
source of bias in our comparisons of economic outcomes
between the high and low CD4þ groups (see Table S3,
http://links.lww.com/QAD/A465 and associated notes).
Finally, we examined whether economic status at baseline
and over time differed for those initiating at CD4þ at least
350. As shown in Figure S1 and Table S4 (http://
links.lww.com/QAD/A465), outcomes at baseline and at
1–2 years of follow-up were substantively similar to
those for initiating at CD4þ above 200 and below 350,
though small sample sizes (only 47 participants initiated
therapy at CD4þ at least 350) precluded any definitive
interpretation.Discussion
Results from this cohort study of HIV-infected adults on
ART in rural Uganda showed that participants initiating
ART at CD4þ at least 200 started out with higher labor
force participation rates relative to their counterparts,
initiating ART at CD4þ below 200. Within 1 year after
starting ART, however, those initiating ART at CD4þ
below 200 had caught up and thereafter maintained
similar trajectories in labor force participation: the overall
6-year change in likelihood of working for adults
initiating at CD4þ below 200 was 20 percentage points.
Interestingly, despite being more likely to be working
at baseline, participants with higher CD4þ cell counts
at initiation reported similar household asset scores as
the lower CD4þ cell count group, with both groups
experiencing increases in asset ownership over the
study period.
These results have several policy implications. Whereas
those initiating ART at CD4þ below 200 caught up
quickly and experienced similar trajectories thereafter,
earlier ART initiation may have prevented households
from experiencing job loss and economic hardship in
the first place, consistent with recent findings by
Thirumurthy et al. [15]. Focusing on labor force
participation alone, however, may mask more subtle
impacts of HIV on individual and household socio-
economic outcomes. In particular, despite being more
likely to work, participants with higher baseline CD4þ
cell counts started with similar asset scores as those
initiating ART at lower CD4þ cell counts. It may be that
durable assets were being sold to make up for unmeasured
declines in productivity or that participants, prior to
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Notes – These figures represent means of the outcome variables at each time point. Labor force participation
= 1 if the participant reported being engaged in any formal or informal income generating activity; hence the
mean is the proportion of the sample working at that time point. Asset score ranges from 0-16 (see Table 1
notes for details on construction). Time on ART = 0 refers to pre-ART baseline. CD4 refers to CD4 count at
the time of ART initiation. Confidence intervals were not displayed so as to improve readability: only the
differences in baseline labor force participation in panel A were statistically significant (p<0.01).     
FIGURE 1. TrendsAQ2 in labor force participation and household asset scores by CD4R cell count at time of ART initiation. Notes:
These figures represent means of the outcome variables at each time point. Labor force participation U 1, if the participant
reported being engaged in any formal or informal income-generating activity; hence the mean is the proportion of the sample
working at that time point. Asset score ranges from 0 to 16 (see Table 1 notes for details on construction). Time on ARTU 0 refers
to pre-ART baseline. CD4R refers to CD4R cell count at the time of ART initiation. Confidence intervals were not displayed so as
to improve readability: only the differences in baseline labor force participation in panel a were statistically significant
(P<0.01).treatment initiation, perceived shorter life expectancies
and therefore did not undertake long-term investments
in productive assets [16]. These alternate mechanisms
deserve further attention and motivate economic inter-
ventions at the time of diagnosis in order to preventnonmorbidity-related economic decline. Finally, con-
tinued improvements in socioeconomic position for
all study participants 6 years after ART initiation
demonstrates that economic impacts of ART may persist
well after immune reconstitution is achieved.
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Table 1. Association between CD4R cell count at baseline and trends in labor force participation and household asset ownership.
1 2
Labor force participation Asset score
Baseline CD4þ cell count
<200 Ref Ref
200 0.13 (0.057, 0.21)MMM 0.0049 (0.47, 0.48)
Time on ART (years)
Baseline Ref Ref
1 0.12 (0.051, 0.18)MMM 0.16 (0.23, 0.56)
2 0.12 (0.057, 0.19)MMM 0.39 (0.016, 0.80)M
3 0.16 (0.10, 0.22)MMM 0.27 (0.12, 0.66)
4 0.18 (0.12, 0.24)MMM 0.70 (0.30,1.10)MMM
5 0.19 (0.13, 0.25)MMM 0.95 (0.52,1.38)MMM
6 0.20 (0.13, 0.28)MMM 1.17 (0.65, 1.70)MMM
Time on ARTCD4þ group interactions
1 yearCD4þ 200 0.12 (0.24, 0.013)M 0.21 (0.48, 0.90)
2 yearsCD4þ 200 0.16 (0.31, 0.001)MM 0.47 (1.24, 0.30)
3 yearsCD4þ 200 0.18 (0.33, 0.025)MM 0.2 (0.93, 0.52)
4 yearsCD4þ 200 0.13 (0.29, 0.026) 0.31 (1.11, 0.49)
5 yearsCD4þ 200 0.07 (0.26, 0.12) 0.11 (0.93, 0.71)
6 yearsCD4þ 200 0.20 (0.44, 0.038)M 0.33 (0.81, 1.47)
Number of participants 505 505
Person-years 2349 2349
Regression coefficients are reported with 95% confidence intervals in parentheses. Each column represents a separate regression. Models for labor
force participation were estimated using probit regression, with the dependent variable equal to 1 if the individual reported participation in any
formal or informal income-generating activity at the time of interview. All models included controls for baseline age, age-squared, a binary variable
for sex, interactions between sex and baseline age, and binary indicators for marital status, completing some secondary schooling, and interview
during the rainy season (see Table S2, http://links.lww.com/QAD/A465 for coefficient estimates on covariates). Reported coefficients are marginal
effects. These can be interpreted as follows: for a continuous variable, the marginal effect coefficient reflects the percentage point increase in the
probability of observing the dependent variable for a 1 unit change in the explanatory variable; for binary variables, it reflects a similar change in the
dependent variable associated with a change from 0 to 1 on the explanatory variable of interest. Models for asset scores (integer ranging from 0 to
16, representing the count of the number of assets owned from the following: iron, gas or electric stove, refrigerator, telephone, motorbike, bicycle,
car, clock, television, radio, bed, sofa, lantern, cupboard, andmattress) were estimated using ordinary least squares regressions. For all models, the
main explanatory variables were CD4þ cell count at baseline and their interactions with the time-on-ART dummy variables. The ‘Number of
participants’ refers to the number of unique individuals in the estimation sample. ‘Person-years’ refers to the total number of person-year
observations.
MP<0.10.
MMP<0.05.
MMMP<0.01.
Confidence intervals computed using heteroskedasticity correct standard errors.The study has several limitations. First, the non-
experimental study design limited our ability to make
causal inferences. Second, we did not observe economic
status prior to the baseline survey, limiting our ability to
characterize the trajectory of pre-ART economic status.
Third, we lacked data on alternate economic measures
such as hours worked or wage earnings, which would
have enabled us to better characterize subtle differences
in productivity across the different CD4þ cell count
groups over the course of ART. Finally, it is unclear
whether our findings generalize to other settings,
though similarities in ART-led economic recovery
across different countries suggest that some degree of
generalization is reasonable [6,10,11].
Understanding the relationship between timing of
ART initiation and economic deterioration is important
for the design of ART guidelines and the valuation of
the economic benefits of early ART initiation. Our study
demonstrates that initiating ARTat CD4þ above 200 may
have helped prevent job loss, though perhaps it did not
help stave off losses in household assets. Future researchshould examine a broader set of socioeconomic outcomes
across a wider range of baseline CD4þ cell counts
(in particular the 350 and 500 thresholds identified in
the 2010 and 2013 WHO guidelines), most optimally in
the setting of a randomized controlled trial, to better
identify ART initiation thresholds in which economic
status is not compromised.Acknowledgements
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